Back to Results

CV Sciences Inc (CVSI)

CV Sciences, Inc. is a common stock listing on OTC Markets for the company of the same name. The San Diego-based business develops, manufactures, markets, and sells herbal supplements, hemp-derived cannabidiol (CBD), and plant-based food products in North America. Its product portfolio is sold under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brands, with distribution spanning the company’s websites, selected distributors, brick-and-mortar retailers, and e-tailers. CV Sciences serves health care-related categories including nutraceuticals, beauty care, specialty foods, and pet products. The company was incorporated in 2010 and adopted its current name in January 2016 after previously operating as CannaVest Corp.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-CVSI
$0.027
43.0% Upside
Undervalued
—
—
—
Weak
—
—
—
0.0%
August 17, 2026
-2.6x
2.6x
0.3x
3.672 M
5.077 M
28.9%
92.2%
-19.7
—
19.9%
Valuation • Fair Value

CV Sciences Inc (OTC-CVSI) Fair Value by Valuation Model

Compare the primary fair value estimate for CV Sciences Inc (OTC-CVSI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.027

Estimated upside of 43.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.025

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.027

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for CV Sciences Inc (OTC-CVSI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for CV Sciences Inc (OTC-CVSI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

13.378 M

Current operating scale indicator.

Revenue Forecast

13.789 M

Forward revenue estimate.

EBITDA

-666 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review CV Sciences Inc (OTC-CVSI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CV Sciences Inc (OTC-CVSI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.41

No elevated caution signal from this screen.

Altman Z-Score

-19.7

Lower score that deserves closer risk review.

FCF / Net Income

19.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CV Sciences Inc (OTC-CVSI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for CV Sciences Inc (OTC-CVSI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 17, 2026

Days to Earnings

27

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for CV Sciences Inc (OTC-CVSI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

CV Sciences Inc (OTC-CVSI) Stock Forecast & Technical Outlook

Review CV Sciences Inc (OTC-CVSI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for CV Sciences Inc (OTC-CVSI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CV Sciences Inc (OTC-CVSI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, CV Sciences Inc (OTC-CVSI) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

CV Sciences Inc (OTC-CVSI) Stock FAQ

Quick answers about CV Sciences Inc (OTC-CVSI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.027
Estimated upside 43.0%
Valuation Rating
Undervalued
Estimated upside of 43.0%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for CV Sciences Inc (OTC-CVSI) is $0.027. This implies an estimated upside of 43.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 43.0% versus the current market price.

An analyst price target for CV Sciences Inc (OTC-CVSI) is not currently available in the latest data file.

The current financial health read for CV Sciences Inc (OTC-CVSI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for CV Sciences Inc (OTC-CVSI) is August 17, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for CV Sciences Inc (OTC-CVSI) is -2.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for CV Sciences Inc is 3.672 M.

The current enterprise value listed for CV Sciences Inc is 5.077 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CV Sciences Inc is OTC-CVSI, and the stock is listed on OTC Markets.

CV Sciences Inc (OTC-CVSI) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for CV Sciences Inc is 28.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CV Sciences Inc is 92.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Personal Care Products Stocks on OTC Markets View more

L’Oreal Co ADR (LRLCY) L’Oreal Co ADR (LRLCY)
Beiersdorf AG ADR (BDRFY) Beiersdorf AG ADR (BDRFY)
Kao Corp ADR (KAOOY) Kao Corp ADR (KAOOY)
Puig Brands SA ADR (PUGBY) Puig Brands SA ADR (PUGBY)
Shiseido Company Ltd (SSDOY) Shiseido Company Ltd (SSDOY)
Hengan International Group Company Ltd ADR (HEGIY) Hengan International Group Company Ltd ADR (HEGIY)
Hengan Intl Group Ltd-H (HEGIF) Hengan Intl Group Ltd-H (HEGIF)
Kose Corp ADR (KSRYY) Kose Corp ADR (KSRYY)
PZ Cussons PLC ADR (PZCUY) PZ Cussons PLC ADR (PZCUY)
Horizon Kinetics Holding Corp (HKHC) Horizon Kinetics Holding Corp (HKHC)
Ascend Wellness Holdings Inc (AAWH) Ascend Wellness Holdings Inc (AAWH)
BioForce Nanosciences Holdings Inc (BFNH) BioForce Nanosciences Holdings Inc (BFNH)
Zivo Bioscience Inc (ZIVO) Zivo Bioscience Inc (ZIVO)
Healthy Extracts Inc (HYEX) Healthy Extracts Inc (HYEX)
Citrine Global Corp (CTGL) Citrine Global Corp (CTGL)
Glucose Health Inc (GLUC) Glucose Health Inc (GLUC)
Smart Trends Network Inc (STSN) Smart Trends Network Inc (STSN)
BioRegenx Inc (BRGX) BioRegenx Inc (BRGX)
Integrated Biopharma Inc (INBP) Integrated Biopharma Inc (INBP)
Cyanotech Corporation (CYAN) Cyanotech Corporation (CYAN)
CCA Industries Inc (CAWW) CCA Industries Inc (CAWW)
Reliv International Inc (RELV) Reliv International Inc (RELV)
Redwood Scientific Technologies Inc (RSCI) Redwood Scientific Technologies Inc (RSCI)
Fuss Brands Corp (FBDS) Fuss Brands Corp (FBDS)